Submission Details
| 510(k) Number | K861373 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 11, 1986 |
| Decision Date | April 18, 1986 |
| Days to Decision | 7 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | — |
K861373 is an FDA 510(k) clearance for the HUMAN LUNG CARCINOMA CELLS (A549), a Cells, Animal And Human, Cultured (Class I — General Controls, product code KIR), submitted by Viromed Laboratories, Inc. (Minneapolis, US). The FDA issued a Cleared decision on April 18, 1986, 7 days after receiving the submission on April 11, 1986. This device falls under the Pathology review panel. Regulated under 21 CFR 864.2280.
| 510(k) Number | K861373 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 11, 1986 |
| Decision Date | April 18, 1986 |
| Days to Decision | 7 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | — |
| Product Code | KIR — Cells, Animal And Human, Cultured |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 864.2280 |